Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine withi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Médiavilla, Clémence, Yon, Edwige, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Forcade, Edouard, Milpied, Noël, Sarry, Audrey, Sauvezie, Mathieu, Bories, Pierre, Pigneux, Arnaud, Récher, Christian
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Clinical Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668025/
https://ncbi.nlm.nih.gov/pubmed/29108292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15988
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg